The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
Abstract
status: Published
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., & Broder, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7096 · Cited by 1,866
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
Gallant, J. E. (2004) · JAMA · doi:10.1001/jama.292.2.191 · Cited by 1,341
Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4721-4732.2005 · Cited by 1,152
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
Little, S. J., Holte, S., Routy, J.-P., Daar, E. S., Markowitz, M., Collier, A. C., Koup, R. A., Mellors, J. W., Connick, E., Conway, B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013552 · Cited by 1,140
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America
Lalezari, J. P., Henry, K., O'Hearn, M., Montaner, J. S. G., Piliero, P. J., Trottier, B., Walmsley, S., Cohen, C., Kuritzkes, D. R., Eron, J. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035026 · Cited by 914
A new classification for HIV-1
Berger, E. A., Doms, R. W., Fenyö, E.-M., Korber, B. T. M., Littman, D. R., Moore, J. P., Sattentau, Q. J., Schuitemaker, H., Sodroski, J., & Weiss, R. A. (1998) · Nature · doi:10.1038/34571 · Cited by 830
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
Donzella, G. A., Schols, D., Lin, S. W., Esté, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., DeClercq, E., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-072 · Cited by 760
Self-citationPotent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
Merluzzi, V. J., Hargrave, K. D., Labadia, M., Grozinger, K., Skoog, M., Wu, J. C., Shih, C.-K., Eckner, K., Hattox, S., Adams, J., et al. (1990) · Science · doi:10.1126/science.1701568 · Cited by 743
Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
Steigbigel, R. T., Cooper, D. A., Kumar, P. N., Eron, J. E., Schechter, M., Markowitz, M., Loutfy, M. R., Lennox, J. L., Gatell, J. M., Rockstroh, J. K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708975 · Cited by 691
Integrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
HIV-1 protease inhibitors. A review for clinicians
Deeks, S. G. (1997) · JAMA · doi:10.1001/jama.277.2.145 · Cited by 675
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
Lazzarin, A., Clotet, B., Cooper, D., Reynes, J., Arastéh, K., Nelson, M., Katlama, C., Stellbrink, H.-J., Delfraissy, J.-F., Lange, J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035211 · Cited by 656
Strategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Self-citationSumma, V., Petrocchi, A., Bonelli, F., Crescenzi, B., Donghi, M., Ferrara, M., Fiore, F., Gardelli, C., Gonzalez Paz, O., Hazuda, D. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800245z · Cited by 633
Large-scale manufacture of peptide therapeutics by chemical synthesis
Bray, B. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1133 · Cited by 598
Grinsztejn, B., Nguyen, B.-Y., Katlama, C., Gatell, J. M., Lazzarin, A., Vittecoq, D., Gonzalez, C. J., Chen, J., Harvey, C. M., & Isaacs, R. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60597-2 · Cited by 574
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554
Kashman, Y., Gustafson, K. R., Fuller, R. W., Cardellina, J. H., McMahon, J. B., Currens, M. J., Buckheit, R. W., Hughes, S. H., Cragg, G. M., & Boyd, M. R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00093a004 · Cited by 552
Engelman, A., & Craigie, R. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6361-6369.1992 · Cited by 519
Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
Cooper, D. A., Steigbigel, R. T., Gatell, J. M., Rockstroh, J. K., Katlama, C., Yeni, P., Lazzarin, A., Clotet, B., Kumar, P. N., Eron, J. E., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708978 · Cited by 509
Hendrix, C. W., Flexner, C., MacFarland, R. T., Giandomenico, C., Fuchs, E. J., Redpath, E., Bridger, G., & Henson, G. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1667-1673.2000 · Cited by 504
Strategies for antiviral therapy in AIDS
Mitsuya, H., & Broder, S. (1987) · Nature · doi:10.1038/325773a0 · Cited by 487
Wild, C., Oas, T., McDanal, C., Bolognesi, D., & Matthews, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10537 · Cited by 485
Young, S. D., Britcher, S. F., Tran, L. O., Payne, L. S., Lumma, W. C., Lyle, T. A., Huff, J. R., Anderson, P. S., Olsen, D. B., & Carroll, S. S. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2602 · Cited by 482
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes
Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R., & Bolognesi, D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1331 · Cited by 465
De Clercq, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1134 · Cited by 460
Self-citationHIV-1 Protease Inhibitors: A Review for Clinicians
Deeks, S. G. (1997) · JAMA · doi:10.1001/jama.1997.03540260059037 · Cited by 434
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
Rimsky, L. T., Shugars, D. C., & Matthews, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.986-993.1998 · Cited by 423
Prodrugs of Phosphates and Phosphonates
Hecker, S. J., & Erion, M. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701260b · Cited by 414
Markowitz, M., Nguyen, B.-Y., Gotuzzo, E., Mendo, F., Ratanasuwan, W., Kovacs, C., Prada, G., Morales-Ramirez, J. O., Crumpacker, C. S., Isaacs, R. D., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318157131c · Cited by 408
Michaels, S. H., Clark, R. A., & KISSINGER, P. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390612 · Cited by 402
A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion
Wild, C., Greenwell, T., & Matthews, T. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1051 · Cited by 398
Daluge, S. M., Good, S. S., Faletto, M. B., Miller, W. H., St Clair, M. H., Boone, L. R., Tisdale, M., Parry, N. R., Reardon, J. E., Dornsife, R. E., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1082 · Cited by 384
Devine, S. M., Flomenberg, N., Vesole, D. H., Liesveld, J., Weisdorf, D., Badel, K., Calandra, G., & DiPersio, J. F. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.131 · Cited by 368
Kumar, G. N., Rodrigues, A. D., Buko, A. M., & Denissen, J. F. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12840-1 · Cited by 353
Engelman, A., Bushman, F. D., & Craigie, R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05996.x · Cited by 350
García-Lerma, J. G., Otten, R. A., Qari, S. H., Jackson, E., Cong, M.-E., Masciotra, S., Luo, W., Kim, C., Adams, D. R., Monsour, M., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050028 · Cited by 350
Janssen, P. A. J., Lewi, P. J., Arnold, E., Daeyaert, F., de Jonge, M., Heeres, J., Koymans, L., Vinkers, M., Guillemont, J., Pasquier, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040840e · Cited by 347
A Pathogenic Retrovirus (HTLV-III) Linked to AIDS
Broder, S., & Gallo, R. C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411153112006 · Cited by 335
Orner, B. P., Ernst, J. T., & Hamilton, A. D. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0025548 · Cited by 320
Schinazi, R. F., McMillan, A., Cannon, D., Mathis, R., Lloyd, R. M., Peck, A., Sommadossi, J. P., St Clair, M., Wilson, J., & Furman, P. A. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.11.2423 · Cited by 294
Baba, M., Tanaka, H., De Clercq, E., Pauwels, R., Balzarini, J., Schols, D., Nakashima, H., Perno, C.-F., Walker, R. T., & Miyasaka, T. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92756-3 · Cited by 288
Self-citationEsté, J. A., & Telenti, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61052-6 · Cited by 287
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy
Balzarini, J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1707 · Cited by 283
The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
De Clercq, E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.014 · Cited by 277
Self-citationSchinazi, R. F., Chu, C. K., Peck, A., McMillan, A., Mathis, R., Cannon, D., Jeong, L. S., Beach, J. W., Choi, W. B., & Yeola, S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.3.672 · Cited by 265
HIV Integrase, a Brief Overview from Chemistry to Therapeutics
Craigie, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100027200 · Cited by 258
The AIDS Epidemic — Considerations for the 21st Century
Fauci, A. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411406 · Cited by 257
Otten, R. A., Smith, D. K., Adams, D. R., Pullium, J. K., Jackson, E., Kim, C. N., Jaffe, H., Janssen, R., Butera, S., & Folks, T. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9771-9775.2000 · Cited by 239
Gulick, R. M., Su, Z., Flexner, C., Hughes, M. D., Skolnik, P. R., Wilkin, T. J., Gross, R., Krambrink, A., Coakley, E., Greaves, W. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/518797 · Cited by 239
Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Past, Present, and Future
De Clercq, E. (2004) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490012 · Cited by 238
Self-citationInhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS
Rice, W. G., Supko, J. G., Malspeis, L., Buckheit, R. W., Clanton, D., Bu, M., Graham, L., Schaeffer, C. A., Turpin, J. A., Domagala, J., et al. (1995) · Science · doi:10.1126/science.270.5239.1194 · Cited by 236
Arribas, J. R., Pozniak, A. L., Gallant, J. E., DeJesus, E., Gazzard, B., Campo, R. E., Chen, S.-S., McColl, D., Holmes, C. B., Enejosa, J., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815acab8 · Cited by 235
New Approaches toward Anti-HIV Chemotherapy
De Clercq, E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040158k · Cited by 235
Self-citationBalzarini, J. M., Kang, G.-J., Dalal, M., Herdewijn, P. A., Clercq, E. D., Broder, S. W., & Johns, D. G. (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13752-8 · Cited by 233
Sanne, I., Piliero, P., Squires, K., Thiry, A., & Schnittman, S. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200301010-00004 · Cited by 226
Trkola, A., Ketas, T. J., Nagashima, K. A., Zhao, L., Cilliers, T., Morris, L., Moore, J. P., Maddon, P. J., & Olson, W. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.579-588.2001 · Cited by 224
Flavin, M. T., Rizzo, J. D., Khilevich, A., Kucherenko, A., Sheinkman, A. K., Vilaychack, V., Lin, L., Chen, W., Greenwood, E. M., Pengsuparp, T., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950797i · Cited by 219
Strizki, J. M., Tremblay, C., Xu, S., Wojcik, L., Wagner, N., Gonsiorek, W., Hipkin, R. W., Chou, C.-C., Pugliese-Sivo, C., Xiao, Y., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4911-4919.2005 · Cited by 213
Antiretroviral resistance during successful therapy of HIV type 1 infection
Martinez-Picado, J., DePasquale, M. P., Kartsonis, N., Hanna, G. J., Wong, J., Finzi, D., Rosenberg, E., Günthard, H. F., Sutton, L., Savara, A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10948 · Cited by 209
Small-molecule inhibition of HIV-1 Vif
Nathans, R., Cao, H., Sharova, N., Ali, A., Sharkey, M., Stranska, R., Stevenson, M., & Rana, T. M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1496 · Cited by 198
Short constrained peptides that inhibit HIV-1 entry
Sia, S. K., Carr, P. A., Cochran, A. G., Malashkevich, V. N., & Kim, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232566599 · Cited by 195
Toxicity of antiretroviral therapy and implications for drug development
Carr, A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1151 · Cited by 191
Subbarao, S., Otten, R. A., Ramos, A., Kim, C., Jackson, E., Monsour, M., Adams, D. R., Bashirian, S., Johnson, J., Soriano, V., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/507306 · Cited by 191
Evolution of anti-HIV drug candidates. Part 3: diarylpyrimidine (DAPY) analogues
Ludovici, D. W., De Corte, B. L., Kukla, M. J., Ye, H., Ho, C. Y., Lichtenstein, M. A., Kavash, R. W., Andries, K., de Béthune, M.-P., Azijn, H., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00412-7 · Cited by 185
Budihas, S. R. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki268 · Cited by 180
Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives
Balzarini, J. (1994) · Pharmacy World & Science · doi:10.1007/bf01880662 · Cited by 172
Ernst, J. T., Kutzki, O., Debnath, A. K., Jiang, S., Lu, H., & Hamilton, A. D. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020118)41:2<278::aid-anie278>3.0.co;2-a · Cited by 172
Birkus, G., Wang, R., Liu, X., Kutty, N., MacArthur, H., Cihlar, T., Gibbs, C., Swaminathan, S., Lee, W., & McDermott, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00968-06 · Cited by 172
Cassetti, I., Madruga, J. V. R., Suleiman, J. M. A. H., Etzel, A., Zhong, L., Cheng, A. K., Enejosa, J., & for the Study 903E Team (2007) · HIV Clinical Trials · doi:10.1310/hct0803-164 · Cited by 168
Structural and biochemical studies of retroviral proteases
Wlodawer, A., & Gustchina, A. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00267-8 · Cited by 166
Acyclic nucleoside phosphonates: Past, present and future
Clercq, E. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.09.014 · Cited by 149
U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication
Dueweke, T. J., Poppe, S. M., Romero, D. L., Swaney, S. M., So, A. G., Downey, K. M., Althaus, I. W., Reusser, F., Busso, M., & Resnick, L. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1127 · Cited by 144
Gosselin, G., Schinazi, R. F., Sommadossi, J., Mathé, C., Bergogne, M. C., Aubertin, A.-M., Kirn, A., & Imbach, J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1292 · Cited by 133
Rompay, K. K. A. V., McChesney, M. B., Aguirre, N. L., Schmidt, K. A., Bischofberger, N., & Marthas, M. L. (2001) · The Journal of Infectious Diseases · doi:10.1086/322781 · Cited by 121
Tramontano, E., Esposito, F., Badas, R., Santo, R. D., Costi, R., & Colla, P. L. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2004.11.002 · Cited by 121
Greene, W. C., Debyser, Z., Ikeda, Y., Freed, E. O., Stephens, E. B., Yonemoto, W. M., Buckheit, R. W., Esté, J. A., & Cihlář, T. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.08.003 · Cited by 121
Balzarini, J. M. (2007) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020701800101 · Cited by 109
Cos, P., Maes, L. J. R. M., Vlietinck, A. J., & Pieters, L. A. C. (2008) · Planta Medica · doi:10.1055/s-2008-1081314 · Cited by 108
Pauwels, R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.07.005 · Cited by 104
Balzarini, J. M., Laethem, K. V., Daelemans, D., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01404-06 · Cited by 104
DATEMA, R., Rabin, L. B., Hincenbergs, M., Moreno, M. B., Warren, S., Linquist-Stepps, V. D., Rosenwirth, B., SEIFERT, J. ‐., & McCune, J. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.750 · Cited by 102
Plosker, G. L., & Noble, S. (1999) · Drugs · doi:10.2165/00003495-199958060-00011 · Cited by 101
Fikkert, V., Maele, B. V., Vercammen, J., Hantson, A., Remoortel, B. V., Michiels, M., Gurnari, C., Pannecouque, C. C., Maeyer, M. D., Engelborghs, Y., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11459-11470.2003 · Cited by 98
Bazmi, H., Hammond, J., Cavalcanti, S. C. H., Chu, C. K., Schinazi, R. F., & Mellors, J. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1783-1788.2000 · Cited by 95
Creagh-Kirk, T., Ruckle, J., Tolbert, D. T., Giltner, J., Eiznhamer, D. A., Dutta, B., Flavin, M. T., & Xu, Z. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1379-1386.2001 · Cited by 94
Cihlář, T., Ray, A. S., Boojamra, C. G., Zhang, L., Hui, H. C., Laflamme, G., Vela, J. E., Grant, D., Chen, J., Myrick, F. T., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01215-07 · Cited by 93
Weber, J., Chakraborty, B., Weberová, J., Miller, M. D., & Quiñones‐Mateu, M. E. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.3.1395-1400.2005 · Cited by 88
Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections
Clercq, E. D. (2003) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.1.1.21 · Cited by 84
Adkins, J. C., & Faulds, D. M. (1998) · Drugs · doi:10.2165/00003495-199855060-00015 · Cited by 74
Lalezari, J. P., Yadavalli, G., Para, M. F., Richmond, G. J., DeJesus, E., Brown, S. J., Cai, W., Chen, C., Zhong, J., Novello, L. A., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527327 · Cited by 73
Long-Term HIV/AIDS Survival Estimation in the Highly Active Antiretroviral Therapy Era
King, J. T., Justice, A. C., Roberts, M. S., et al. (2003) · Medical Decision Making · doi:10.1177/0272989x02239652 · Cited by 72
Gu, Z., Wainberg, M. A., Nguyen‐Ba, N., L’Heureux, L., de Muys, J.-M., Bowlin, T. L., & Rando, R. F. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2376 · Cited by 70
Mewshaw, J. P., Myrick, F. T., Wakefield, D. A. C. S., Hooper, B. J., Harris, J. L., McCreedy, B. J., & Borroto–Esoda, K. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200201010-00002 · Cited by 67
McGuigan, C., Hassan-Abdallah, A., Srinivasan, S., Wang, Y., Siddiqui, A. Q., Daluge, S. M., Gudmundsson, K. S., Zhou, H., McLean, E. W., Peckham, J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060776w · Cited by 61
Takashima, K., Miyake, H., Kanzaki, N., Tagawa, Y., Wang, X., Sugihara, Y., Iizawa, Y., & Baba, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3474-3482.2005 · Cited by 60
de Muys, J.-M., Gourdeau, H., Nguyen‐Ba, N., Taylor, D. L., Ahmed, P. S., Mansour, T. S., Locas, C., Richard, N., Wainberg, M. A., & Rando, R. F. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1835 · Cited by 58
Siddiqui, A. Q., McGuigan, C., Ballatore, C., Zuccotto, F., Gilbert, I. H., Clercq, E. D., & Balzarini, J. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9807104 · Cited by 57
Pelemans, H., Esnouf, R. M., Clercq, E. D., & Balzarini, J. M. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26505-6 · Cited by 51
Kitchen, C. M., Kitchen, S. G., Dubin, J. A., & Gottlieb, M. S. (2001) · Clinical Infectious Diseases · doi:10.1086/321900 · Cited by 50
Domaoal, R. A., & Demeter, L. M. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.026 · Cited by 49
Bethell, R. C., Lie, Y., & Parkin, N. T. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600502 · Cited by 38
Pollicita, M., Schols, D., Aquaro, S., Peumans, W. J., Damme, E. J. M. V., Perno, C. F., & Balzarini, J. M. (2007) · Virology · doi:10.1016/j.virol.2007.08.033 · Cited by 36
Strategies for Inhibiting Function of HIV-1 Accessory Proteins: A Necessary Route to AIDS Therapy?
Richter, S. N., Frasson, I., & Palù, G. (2008) · Current Medicinal Chemistry · doi:10.2174/092986709787002646 · Cited by 31
Prada, N., Davis, B., Jean-Pierre, P., Roche, M. L., Duh, F.-M. C., Carrington, M. N., Poles, M. A., Mehandru, S., Mohri, H., & Markowitz, M. H. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181869a9b · Cited by 25
Chong, Y., Borroto–Esoda, K., Furman, P. A., Schinazi, R. F., & Chu, C. K. (2002) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020201300205 · Cited by 21
Recent Advances in the Research of HIV-1 RNase H Inhibitors
Yu, F., Liu, X., Zhan, P., & Clercq, E. D. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786141052 · Cited by 20
Arrizabalaga, J., Arazo, P., Aguirrebengoa, K., García-Palomo, D., Chocarro, Á., Labarga, P., Muñoz-Sánchez, M.-J., Echevarría, S., Oteo, J. A., Úriz, J., et al. (2007) · HIV Clinical Trials · doi:10.1310/hct0805-328 · Cited by 16
Cited by
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
Fleming, F. F., Yao, L., Ravikumar, P. C., Funk, L., & Shook, B. C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100762r · Cited by 1,754
Mäder, P., & Kattner, L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00960 · Cited by 438
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
Ghosh, A. K., Osswald, H. L., & Prato, G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01697 · Cited by 419
Jayakumar, T., Hsieh, C.-Y., Lee, J.-J., & Sheu, J.-R. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/846740 · Cited by 301
Cuzzucoli Crucitti, G., Métifiot, M., Pescatori, L., Messore, A., Madia, V. N., Pupo, G., Saccoliti, F., Scipione, L., Tortorella, S., Esposito, F., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501799k · Cited by 81
Metadata
- Authors
- Mehellou, Y., & De Clercq, E.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-09-28
- Volume
- 53
- Issue
- 2
- Pages
- 521-538
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2031991206
- Cited by
- 368
- References
- 114
- FWCI
- 23.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.